CHC Healthcare Group

TPE:4164 (Taiwan)  
NT$ 52.10 (+2.36%) Jun 7
28.15
P/B:
1.41
Market Cap:
NT$ 8.69B ($ 268.07M)
Enterprise V:
NT$ 11.93B ($ 368.22M)
Volume:
430.05K
Avg Vol (2M):
581.76K
Volume:
430.05K
Avg Vol (2M):
581.76K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for CHC Healthcare Group ( TPE:4164 ) from 2012 to Jun 08 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. CHC Healthcare Group stock (TPE:4164) PE ratio as of Jun 08 2024 is 28.15. More Details

CHC Healthcare Group (TPE:4164) PE Ratio (TTM) Chart

To

CHC Healthcare Group (TPE:4164) PE Ratio (TTM) Historical Data

Total 1208
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
CHC Healthcare Group PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-08 28.2 2024-04-03 32.8
2024-06-07 28.2 2024-04-02 32.4
2024-06-06 27.5 2024-04-01 32.5
2024-06-05 27.7 2024-03-29 32.6
2024-06-04 28.2 2024-03-28 32.7
2024-06-03 28.2 2024-03-27 26.9
2024-05-31 28.4 2024-03-26 26.3
2024-05-30 28.4 2024-03-25 26.7
2024-05-29 28.8 2024-03-22 27.3
2024-05-28 29.2 2024-03-21 27.2
2024-05-27 28.5 2024-03-20 27.0
2024-05-24 28.3 2024-03-19 26.3
2024-05-23 28.3 2024-03-18 26.0
2024-05-22 28.4 2024-03-15 25.5
2024-05-21 28.4 2024-03-14 25.4
2024-05-20 28.8 2024-03-13 25.6
2024-05-17 28.3 2024-03-12 26.1
2024-05-16 28.2 2024-03-11 25.9
2024-05-15 28.3 2024-03-08 26.1
2024-05-14 28.3 2024-03-07 26.8
2024-05-13 28.2 2024-03-06 26.7
2024-05-10 28.5 2024-03-05 26.5
2024-05-09 27.9 2024-03-04 26.6
2024-05-08 28.4 2024-03-01 27.0
2024-05-07 28.2 2024-02-29 27.2
2024-05-06 28.8 2024-02-27 26.9
2024-05-03 28.6 2024-02-26 27.2
2024-05-02 29.8 2024-02-23 26.8
2024-04-30 30.1 2024-02-22 27.0
2024-04-29 30.3 2024-02-21 27.2
2024-04-26 30.2 2024-02-20 27.4
2024-04-25 30.3 2024-02-19 27.3
2024-04-24 30.5 2024-02-16 25.2
2024-04-23 30.5 2024-02-15 25.2
2024-04-22 30.5 2024-02-05 25.0
2024-04-19 30.1 2024-02-02 25.3
2024-04-18 31.4 2024-02-01 25.5
2024-04-17 30.9 2024-01-31 25.0
2024-04-16 30.9 2024-01-30 25.1
2024-04-15 31.9 2024-01-29 25.4
2024-04-12 32.2 2024-01-26 25.1
2024-04-11 32.2 2024-01-25 25.3
2024-04-10 33.2 2024-01-24 25.7
2024-04-09 32.5 2024-01-23 25.8
2024-04-08 32.8 2024-01-22 25.7

CHC Healthcare Group (TPE:4164) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
CHC Healthcare Group is a Taiwan-based company engaged in the trading of pharmaceutical products and the sale, leasing, installation, and repair of medical instruments. It is engaged in the distribution of radiotherapy equipment, including equipment that is used in the treatment of radiation oncology, ophthalmology, dentistry, and neuroscience. It also provides medical equipment consulting for hospitals and clinics. It earns revenues from the sale of drugs, sale of medical instruments, repairs maintenance, and other services.